CIK 0001875558
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862405608
- Phone
- +1 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- 4 Open-market buy Chairman & CEO bought 320 shares at $17.03 ($5,448)
- 4 Open-market buy Chief Science & Business Off bought 500 shares at $11.55 ($5,775)
- 4 Open-market buy Chairman & CEO bought 230 shares at $12.13 ($2,790)
- 4 Open-market buy Chairman & CEO bought 480 shares at $12.08 ($5,798)
- 4 Open-market buy Chief Dev. & Ops. Officer bought 420 shares at $11.99 ($5,036)
- 4 Open-market buy Chief Dev. & Ops. Officer bought 670 shares at $10.71 ($7,176)
- 4 Open-market buy Chairman & CEO bought 2,160 shares at an average $10.86 ($23,465)
- 4 Grant or award Chief Science & Business Off acquired 115,000 shares (grant or award)
- 4 Grant or award Chairman & CEO acquired 210,000 shares (grant or award)
- 4 Grant or award Chief Dev. & Ops. Officer acquired 115,000 shares (grant or award)
- 4 Open-market buy Chief Dev. & Ops. Officer bought 500 shares at $7.65 ($3,825)
- 4 Open-market buy Chairman & CEO bought 150 shares at $7.45 ($1,118)
- 4 Open-market buy Chairman & CEO bought 450 shares at an average $7.41 ($3,335)
- 4 Open-market buy Chairman & CEO bought 750 shares at an average $7.23 ($5,425)
- 4 Open-market buy Chief Dev. & Ops. Officer bought 300 shares at an average $7.15 ($2,145)
- 4 Open-market buy Chairman & CEO bought 1,000 shares at $7.07 ($7,070)
- 4 Open-market buy Chairman & CEO bought 1,000 shares at an average $7.35 ($7,345)
- 4 Open-market buy Chief Dev. & Ops. Officer bought 220 shares at $7.87 ($1,731)
- 4 Open-market buy Chairman & CEO bought 1,500 shares at an average $7.85 ($11,775)
- 4 Open-market buy Chairman & CEO bought 1,700 shares at an average $8.29 ($14,099)
Page 5 of 7 · 139 filings